Clinical Research

BreatheReady Therapy is 100% natural, safe and drug free. In Europe, dry salt aerosol therapy has been medically recognized for over 50 years for the treatment of breathing and skin problems. Worldwide thousands of people have successfully improved their breathing and health of skin achieving natural symptom relief.

Major European clinical findings:

  • Efficacy is estimated up to 98% for some conditions according to the clinical study “Halotherapy for Therapy of Respiratory Diseases,” published in the Journal of Aerosol Medicine Volume 8, Number 3, 1995.
  • Russian pulmonologist, Alina Chervinskaya, says that 10 to 20 sessions in salt therapy rooms using dry salt aerosol therapy has long-term benefits up to six months or a year.
  • The number and intensity of asthma attacks was reduced and respiratory discomfort decreased or disappeared. In a number of cases the reduction or elimination of prescribed beta­-agonists (medications that mainly affect the muscles around the airways bronchi and bronchioles; when the lungs are irritated, bands of muscle around the airways tighten, making the airways narrower. This often results in breathlessness).*
  • Increased drainage function of patient airways was observed along with lessening of sputum or phlegm (mucus from the lungs) secretion, decrease in viscosity (being thick, sticky, and semi-fluid in consistency) and relief from coughs.*
  • Improved mucociliary clearance (The entire respiratory system is lined with cells that secrete mucus. Airway mucus is a complex substance that forms a protective barrier lining the respiratory tract) and decrease of bronchial inflammation was evident*
  • Average amount of neutrophils (type of white blood cell), macrophages (type of white blood cell that engulf and digest cellular debris, foreign substances,microbes, and cancer cells) and lymphocytes (a type of white blood cell used to evaluate and manage disorders of the blood or the immune system) was diminished.*
  • Observed decrease in the amount of neutrophils and pathogenic microorganisms (invasion and multiplication of pathogenic microorganisms in the body is called an infection. When we are infected by pathogens we become sick, which means that our bodies stop functioning properly) and an in­crease in the amount of alveolar macrophages (or dust cell, activity of the alveolar macrophage should be relatively high because they are located at one of the major boundaries between the body and the outside world) in bronchial secretion of patients with bronchial asthma, chronic obstructive bronchitis and cystic fibrosis after Halotherapy.(Voronina at al, 1994)*
  • Elimination of pathogenic microorganisms and a decrease in inflammatory reaction of the mucosa (mucus membrane is moist tissue that lines certain parts of the inside of your body. It is in your nose, mouth, lungs, and the urinary and digestive tracts. Glands in this tissue release a thick fluid called mucus.) was observed.*
  • Research confirmed the positive effects of Halotherapy on the state of humoral (also called the antibody-mediated immune system, is the aspect of immunity that is mediated by macromolecules found in extracellular fluids such as secreted antibodies, complement proteins and certain antimicrobial peptides) and cellular immunity in patients with bronchial asthma (Spesivykh et al, 1990, Torokhtin et al, 1987); decrease of IgE level was observed. (Dityatkovskaya et al, 1993)*
  • Contributed bactericidal (capable of killing bacteria outright) and bacteriostatic (capable of inhibiting the growth or reproduction of bacteria) effects on the respiratory airways microflora (bacteria and microscopic algae and fungi) and showed prevention of the development of inflammatory processes. (Simyonka, 1989, Rein & Mandell, 1973)*
  • Low doses of dry salt aerosol therapy had a beneficial effect on phagocytic activity (a cell that engulfs and absorbs waste material, harmful microorganisms, or other foreign bodies in the bloodstream and tissues) of alveolar macrophages (Konovalov et al, 1992) and thus on bronchial clearance and elimination of foreign agents.*
  • Relieved cough, improved sputum or phlegm (mucus from the lungs) properties, improved auscultation (action of listening to the lungs using a stethoscope) findings and functional pa­rameters. Inhalation of dry sodium chloride aerosol characterized by fixed density and low doses of sodium chloride, rendered sanitary action in the respiratory tract and it was noted that the therapy could be used for primary prevention of COPD.**
  • Reduction in bronchial hyperresponsiveness (increase in sensitivity to a wide variety of airway narrowing stimuli. Most patients with asthma and chronic obstructive pulmonary disease exhibit such an enhanced sensitivity) as an add-on therapy in asthmatics with low to moder­ate doses of inhaled steroids.***

* Chervinskaya AV, Zilber NA. Halotherapy for treatment of respiratory diseases. J Aerosol Med 1995:8(3):221-232.
** Chervinskaya AV. Respiratory hygiene with dry sodium chloride aerosol. 14th Annual Congress of the Respiratory Society, Glasgow, September 2004. Session “Clinical and physiological observations from health to chronic illness”, Poster P2514
*** J. Hedman, T. Hugg, J. Sandell, T. Haahtela. The effect of salt chamber treatment on bronchial hyperresponsiveness in asthmatics. Allergy 2006: 61: 605-610